Literature DB >> 31231002

The missing piece: Clinical pharmacists enhancing the interprofessional nephrology clinic model.

Chelsea E Hawley, Laura K Triantafylidis, Julie M Paik.   

Abstract

OBJECTIVES: To embed pharmacy residents in an interprofessional nephrology clinic to conduct medication reconciliation in targeted high-risk patients with nondialysis kidney disease.
SETTING: This pilot was a prospective quality improvement initiative conducted in an interprofessional outpatient nephrology clinic. PRACTICE DESCRIPTION: The nephrology clinic team includes nephrology providers, a social worker, and a geriatrician. The team is responsible for the management of conditions such as nondialysis kidney disease, resistant hypertension, acute kidney injury, proteinuria, and nephropathy. EVALUATION: Primary outcomes included the number and type of medication discrepancies and drug therapy problems identified. Secondary outcomes included the changes in care process directly resulting from the pharmacy residents' recommendations. The perceived value of the pharmacy residents to the interprofessional team was assessed through postintervention anonymous surveys and semistructured interviews.
RESULTS: The pharmacy residents conducted 118 visits for 87 unique patients (mean age 73 years, 97% male) with nondialysis kidney disease (89% stages III-V), polypharmacy (87% of patients taking > 10 medications), and a heavy comorbidity burden (85% hypertension, 80% dyslipidemia, 59% diabetes mellitus type II) from January to October 2017. Pharmacists identified 344 medication discrepancies and 301 drug therapy problems, resulting in 398 changes in care process. The most frequently identified discrepancies and drug therapy problems were the omission of an active medication from the medication list (86 of 344 discrepancies, 25%) and potentially inappropriate medications (106 of 301 drug therapy problems, 35%). Pharmacists recommended 228 medication changes, provided 76 adherence devices, facilitated 24 consults or referrals, and communicated with the primary care team on 70 occasions. The interprofessional team members all strongly agreed that patients and the team benefited from the pharmacists' involvement.
CONCLUSION: Pharmacy resident-led medication reconciliation resulted in the identification and resolution of medication discrepancies and drug therapy problems, leading to changes in the care process. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31231002      PMCID: PMC8150925          DOI: 10.1016/j.japh.2019.05.010

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  63 in total

1.  Medication-related problems in ambulatory hemodialysis patients: a pooled analysis.

Authors:  Harold J Manley; Carrie A Cannella; George R Bailie; Wendy L St Peter
Journal:  Am J Kidney Dis       Date:  2005-10       Impact factor: 8.860

2.  Enhancing patient engagement and blood pressure management for renal transplant recipients via home electronic monitoring and web-enabled collaborative care.

Authors:  Edward W Aberger; Daniel Migliozzi; Michael J Follick; Tom Malick; David K Ahern
Journal:  Telemed J E Health       Date:  2014-07-21       Impact factor: 3.536

3.  Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.

Authors:  Christina Collins; Amy Kramer; Mary Ellen O'Day; Mary Beth Low
Journal:  Am J Health Syst Pharm       Date:  2006-09-15       Impact factor: 2.637

Review 4.  New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management.

Authors:  Wendy L St Peter; Lori D Wazny; Uptal D Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

Review 5.  Polypharmacy and medication-related complications in the chronic kidney disease patient.

Authors:  Nancy A Mason
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-09       Impact factor: 2.894

6.  Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.

Authors:  Caitlin McIntyre; Rory McQuillan; Chaim Bell; Marisa Battistella
Journal:  Am J Kidney Dis       Date:  2017-04-14       Impact factor: 8.860

Review 7.  The patient-centered medical home and the nephrologist.

Authors:  Lawrence S Weisberg
Journal:  Adv Chronic Kidney Dis       Date:  2011-11       Impact factor: 3.620

8.  Role of clinical pharmacist in the management of blood pressure in dialysis patients.

Authors:  Bonyan Qudah; Abla Albsoul-Younes; Ezat Alawa; Nabil Mehyar
Journal:  Int J Clin Pharm       Date:  2016-05-18

9.  Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.

Authors:  H Y Wang; A L F Chan; M T Chen; C H Liao; Y F Tian
Journal:  Transplant Proc       Date:  2008-09       Impact factor: 1.066

10.  Changing transplant recipient education and inpatient transplant pharmacy practices: a single-center perspective.

Authors:  Angela Q Maldonado; Douglas L Weeks; Amanda N Bitterman; Jo Ann McCleary; Todd C Seiger; Richard W Carson; Patrick K Tabon; Angela L Goroski; Okechukwu N Ojogho
Journal:  Am J Health Syst Pharm       Date:  2013-05-15       Impact factor: 2.637

View more
  2 in total

Review 1.  Drug-drug interactions in polypharmacy patients: The impact of renal impairment.

Authors:  Bianca Papotti; Cinzia Marchi; Maria Pia Adorni; Francesco Potì
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-03-29

2.  Rapid Integration of Home Telehealth Visits Amidst COVID-19: What Do Older Adults Need to Succeed?

Authors:  Chelsea E Hawley; Nicole Genovese; Montgomery T Owsiany; Laura K Triantafylidis; Lauren R Moo; Amy M Linsky; Jennifer L Sullivan; Julie M Paik
Journal:  J Am Geriatr Soc       Date:  2020-10-04       Impact factor: 7.538

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.